Skip to main content



Local Cdiff information for Illinois

Illinois

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Illinois.



Local Cdiff information for Illinois

Illinois

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Illinois.

Providers


Dr. Larry Kociolek, MD, MSCI

Ann & Robert H. Lurie Children’s Hospital of Chicago
225 E. Chicago Ave
Chicago 60611
800.543.7362
FMT Provider: No

Dr. Stuart Johnson, MD

Doctor
Loyola University Med Center
2160 S 1st Ave Ste 102
Maywood 60153
(708) 216-3232
FMT Provider: No

Dr. David T. Rubin, MD

Chief, Section of Gastroenterology, Hepatology and Nutrition; Director, Digestive Diseases Center
University of Chicago Medicine
355 E Grand Ave
Chicago60611
(888) 824-0200
FMT Provider: Yes

David Stewart, MD

SIU Medicine
315 W Carpenter Street
Springfield, IL 62702

(217) 545-8000

VISIT WEBSITE>

Regulation


C. diff Infections

Total Reported Cases: 3807
Hospital Onset: 3807
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.83

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: Yes
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: (410 ILCS 522/) Illinois Adverse Health Care Events Reporting Law of 2005

State Contact

Erica Runningdeer, MSN, MPH, RN
Illinois Department of Public Health
Division of Patient Safety and Quality
122 S. Michigan Avenue 7th Floor
Chicago, 60603
(312) 814-2915
(312) 814-1953

CLINICAL TRIALS


ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Type: Observational
Trial No. NCT03325855
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
Gender: All
Age: All ages

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
708-202-8387 ext 27001
Gender: All
Age: 18 Years and older

To Understand the Safety and Effects of a C. Difficile Vaccine

Official Title: A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, Immunogenicity, and Immunopersistence of a Clostridioides Difficile Vaccine Administered in a 2-Dose Regimen With Novel Adjuvants in Healthy Adults
Trial No. NCT05805826
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: Pfizer CT.gov Call Center
Gender: All
Age: 65 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.